Pirnas Variants And Lung Cancer Risk: A Post-Gwas Study

Background: Lung cancer is the most frequently diagnosed cancer and one of the top cause of cancer death worldwide. The recent discovery of PIWI-interacting RNAs (piRNAs), one type of non-coding RNAs, has been shown to be involved in tumorgenesis pathways of various types of cancer types by accumulating evidences. However, the role of piRNAs in lung cancer development is underexplored. Methods: Genotype and phenotype data were obtained from a genome-wide association study of lung cancer risk (3,702 cases and 3,739 controls) and 1,173 imputed piRNAs variants were analyzed by association analysis for lung cancer risk. A secondary expression analysis is also performed for 200 piRNAs to compare their expression levels in 497 lung adenocarcinoma patients versus 46 normal controls. Following in vitro functional analysis was also performed for the piRNAs variants identified from the association analysis. Results: In the association analysis, one SNP (rs1169347) which can be mapped to two piRNAs (piR-5247 and piR-5671) was identified as statistically significantly associated with lung caner risk (FDR P-value Conclusions: This comprehensive post-GWAS study provided important evidences for the role of piRNAs in lung cancer development through either their own functions or interactions with other protein-coding genes